Analyst Price Targets — ENOV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 8, 2026 8:15 pm | — | BMO Capital | $29.00 | $23.63 | TheFly | Enovis initiated with an Outperform at BMO Capital |
| July 6, 2026 12:42 pm | — | Evercore ISI | $32.00 | $24.39 | TheFly | Enovis price target lowered to $32 from $36 at Evercore ISI |
| May 8, 2026 12:00 pm | — | Evercore ISI | $36.00 | $27.28 | TheFly | Enovis price target raised to $36 from $35 at Evercore ISI |
| February 26, 2026 8:48 pm | Mike Matson | Needham | $52.00 | $25.42 | StreetInsider | Enovis Corp (ENOV) PT Raised to $52 at Needham |
| January 6, 2026 11:21 am | Ryan Zimmerman | BTIG | $41.00 | $27.01 | TheFly | Enovis initiated with a Buy at BTIG |
| January 5, 2026 2:50 pm | — | Evercore ISI | $40.00 | $26.66 | TheFly | Enovis price target lowered to $40 from $44 at Evercore ISI |
| January 5, 2026 2:19 pm | Danielle Antalffy | UBS | $50.00 | $27.47 | StreetInsider | Enovis Corp (ENOV) PT Lowered to $50 at UBS, Estimates Updated |
| December 17, 2025 12:24 pm | — | Canaccord Genuity | $50.00 | $26.07 | TheFly | Enovis price target lowered to $50 from $58 at Canaccord |
| November 6, 2024 6:23 pm | Mike Matson | Needham | $65.00 | $43.32 | StreetInsider | Needham Reiterates Buy Rating on Enovis Corp (ENOV) |
| July 2, 2024 8:02 am | Vijay Kumar | Evercore ISI | $62.00 | $44.35 | TheFly | Enovis price target lowered to $62 from $70 at Evercore ISI |
Latest News for ENOV
Dallas, TX, July 17, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2026 financial results on Thursday, August 6th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation…
DALLAS, TX, July 13, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, today announced the U.S. launch of CT-RevitL™, the next-generation veterinary PBM laser therapy system from its Companion Animal Health business. CT-RevitL delivers enhanced clinical performance, greater mobility and a more intuitive treatment experience for veterinary teams and their…
These four under-the-radar stocks are built to benefit from powerful secular trends that could reward patient, long-term investors.
The DonJoy Spinamic® Hybrid Scoliosis Brace is a first-of-its-kind device that integrates rigid corrective elements into a breathable, adjustable design to improve both clinical outcomes and patient compliance in adolescent idiopathic scoliosis The DonJoy Spinamic® Hybrid Scoliosis Brace is a first-of-its-kind device that integrates rigid corrective elements into a breathable, adjustable design to improve both…
Enovis develops orthopedic and rehabilitation devices for healthcare providers, serving a broad spectrum of musculoskeletal patient needs.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ENOV.
U.S. House Trading
No House trades found for ENOV.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.